Navigation Links
YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference
Date:10/1/2010

ongoing and future clinical trials; that our JAK1/2 inhibitor CYT387 and our VDA small molecule CYT997 will generate positive efficacy and safety data in future clinical trials; that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. Except as required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension
2. YM BioSciences reports fiscal year end 2010 operational and financial results
3. Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City
4. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
5. Cardio3 BioSciences Publishes the Science Basis for C-Cure(R) in JACC
6. Signum Biosciences Names Braham Shroot as Chief Executive Officer
7. YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study
8. CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.
9. Ambit Biosciences Announces Transition in Company Leadership
10. Sangamo BioSciences Announces Second Quarter 2010 Conference Call and Webcast
11. Calithera Biosciences Closes $40 Million in Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 CIO Review ( http://www.cioreview.com ... 20 Most Promising Pharma and Life Science Technology Solution ... global compliance software platform for life sciences companies. ... a panel of experts and members of CIO Review’s ... MediSpend Platform has been on our radar for some ...
(Date:4/17/2015)... , April 17, 2015  Guggenheim Securities, the ... today announced the hiring of William Tanner ... Mr. Tanner will start work at Guggenheim ... York office. "Bill brings a ... research, to our experienced and highly acclaimed healthcare team," ...
(Date:4/17/2015)... 2015 Global Stem Cells Group ... Cell Summit 2015 April 27 - 29, 2015 in ... in all areas of stem cell research including applications, ... and regenerative medicine. , The conference will address ... as translational research in stem cell therapies, regenerative medicine, ...
(Date:4/17/2015)... April 17, 2015 BellBrook Labs ... marketing support for the powerful Orthogonal Pooled Screening ... Genomics Center at the Lankenau Institute for Medical ... is to measurably improve successful drug discovery outcomes ... offering rare, drug-like libraries available nowhere else, coupled ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... Genstruct Inc., a,biotechnology company translating the complexity of ... that its president and,CEO, Dr. Keith O. Elliston, ... Trial Summit in Arlington, Va., September 17-18. ... focused on,"Enhancing Development and Commercial Value Added in ...
... Over 20 Targanta-Related Posters and Presentations Accepted ... Targanta Therapeutics,Corporation today announced that 23 ... and its antibiotic drug discovery,platform at the ... and Chemotherapy (ICAAC), taking place in Chicago,September ...
... NORTH BRUNSWICK, New Jersey, September 12, Rosetta ... in,the development of microRNA-based diagnostics and therapeutics, ... Bentwich will present AACR,s,upcoming Molecular Diagnostics in ... focus on Rosetta Genomics,unique microRNA-based technologies and ...
Cached Biology Technology:Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 3Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 4Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 5Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 6Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 7Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference 2
(Date:4/14/2015)... NEW YORK , April 14, 2015 /PRNewswire/ ... Fast IDentity Online (FIDO ® ) Alliance tm ... standards-based specifications. FIDO members commit to share technology ... authentication methods that are interoperable, more secure and ... specifications enable biometric identity verification that protects sensitive ...
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2
... Washington, DC, June 13, 2008 Mary Tyler Moore, ... husband, S. Robert Levine, M.D., presented the sixth annual ... Florida scientists at JDRF,s annual conference today in Washington, ... are Mark Atkinson, Ph.D., director of the JDRF Gene ...
... Julia Zeitlinger, Ph.D., Assistant Investigator, has been named a ... Trusts. The honor carries an award of $240,000 over ... Pew Scholars are selected on the basis of performance ... as contributors in science relevant to human health. The ...
... --- iZumi Bio, Inc. and The J. David Gladstone ... a major research collaboration and licensing agreement to focus ... iPS cells are "reprogrammed" adult cells that have ... stem (ES) cells, yet do not raise the same ...
Cached Biology News:Florida researchers receive JDRF 'Excellence in Clinical Research Award' 2Julia Zeitlinger named Pew Scholar 2
... Experion HighSens reagents and supplies, ... and supplies sufficient to perform high-sensitivity ... chips on the Experion automated electrophoresis ... gel, 20 microliters RNA HighSens stain, ...
...
... BIP-NC H-IPMIK-OH Lyophilized solid. ... LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A ... V5 (Cat. No. 196810) that serves as ... apoptosis (~200 μM). Purity: ≥97% by ...
BD Falcon microtest assay plate. 1536 well 12l, black BD Optilux PS. Polystyrene, nonsterile, no lid (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
Biology Products: